3 coronavirus stocks I’d buy (and some I’d avoid)

The Covid-19 pandemic is changing society in many ways. Here are three coronavirus stocks I’d buy, and some I’d steer clear of.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The coronavirus pandemic has impacted stocks in wildly differing ways. Of course, with the FTSE All-Share index down over 20% since the start of the year, the impact has been severely negative for many stocks.

However, a perhaps surprising number are showing good gains for the year. This, in spite of – or, in some cases, because of – the Covid-19 pandemic. Here, I want to tell you about three coronavirus stocks I’d buy today, and some I’d avoid.

Big pharma

The world’s big pharma companies are working to develop vaccines for Covid-19. They’re hopeful of success. GlaxoSmithKline CEO Emma Walmsley said yesterday she’s optimistic the industry will be able to make an immunisation against Covid-19. And that it’ll be widely available next year.

In the meantime, we’re making progress on treatments that alleviate the impact of the coronavirus. And more will surely be developed. It seems likely we’ll be in a much better place in 2021 than we’ve been in this year.

Big pharma firms like GlaxoSmithKline could make money from vaccines. But for these multi-billion-pound giants it would be just one of many revenue streams. In other words, Covid-19 isn’t the be-all and end-all for them.

Coronavirus stocks I’d avoid

For small companies, a Covid-19 ‘breakthrough’ could have a big impact. I’ve lost track of the number of UK small-caps that have announced they’re working on some Covid-19-related product or service. Traders and speculators seem to have jumped on such announcements, pushing these companies’ shares up to often crazy valuations.

I’d be inclined to avoid any loss-making small-cap that’s garnered investor interest purely on the back of a tilt at a Covid-19 product or service. I suspect most such companies will fall back into obscurity and their share prices to pre-pandemic levels.

In short, I think investors are on dangerous ground backing profitless small-caps that have made speculative – or in some cases fairly spurious – moves to profit from Covid-19.

Coronavirus stocks I’d buy

I’m much more interested in businesses that should benefit from changes in society that the coronavirus is producing or accelerating. I’m referring to things like online shopping and working from home.

Supermarket giant Tesco boldly doubled its online capacity in the first weeks of the pandemic. This took its market share of UK online grocery sales to 33.5%. Before the pandemic, I’d been impressed by the company’s turnaround and fight-back against discounters like Aldi and Lidl. These bricks-and-mortar discounters now have a lot of ground to make up online, as they acknowledge customer habits are changing. I rate Tesco a ‘buy’.

I’d also happily buy shares of Gamma Communications. It’s a leading supplier of unified communications services to the SME, public sector, and enterprise markets. It enables instant messaging, video calling, multi-party conferencing, and all sorts of other stuff. It’s set to benefit from a likely far larger number of people working from home, or partly from home, than before the pandemic.

Finally, I was keen on gold miners last year, due to the rising level of global debt. Due to the pandemic, money printing and debt have absolutely exploded. In my view, the debasing of paper currencies means we’ll see increasing demand for gold. As such, I think FTSE 100 gold miner Polymetal International is a good stock to buy to benefit from the financial fallout of Covid-19.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline and Tesco. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Jumbo jet preparing to take off on a runway at sunset
Investing Articles

Down 70%+ since 2020, is IAG’s share price an unmissable bargain?

IAG’s share price is still down around 73% from its pre-Covid level, but with the business performing well last year,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

£17,000 of shares in the FTSE 100 dividend giant can make me £18,874 every year in passive income!

This FTSE 100 dividend superstar has an 8.8% yield with dividends projected to rise. It looks very undervalued to me…

Read more »

Investing Articles

2 top UK growth stocks I’m buying for my Stocks and Shares ISA in July

Looking for UK-listed growth firms to add to a Stocks and Shares ISA? Our writer highlights two he's planning to…

Read more »

artificial intelligence investing algorithms
Investing Articles

This overvalued growth stock makes Nvidia look cheap!

ARM Holdings is a growth stock that’s benefitted from the AI rally. Muhammad Cheema takes a look at whether this…

Read more »

Investing Articles

1 penny stock I’d buy today while it’s 63p

This penny stock's down 70% since last March, yet could be set for a big comeback as the firm rebuilds…

Read more »

Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
Investing Articles

Buying 8,617 Legal & General shares would give me a stunning income of £1,840 a year

Legal & General shares offer one of the highest dividend yields on the entire FTSE 100. Harvey Jones wants to…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

£25k to invest? Here’s how I’d try to turn that into a second income of £12,578 a year!

If Harvey Jones had a lump sum to invest today he'd go flat out buying top FTSE 100 second income…

Read more »

Union Jack flag in a castle shaped sandcastle on a beautiful beach in brilliant sunshine
Investing Articles

2 lesser-known dividend stocks to consider this summer

Summer is here and global markets could be heading for a period of subdued trading. But our writer thinks there…

Read more »